Literature DB >> 15709961

Ligand control of coregulator recruitment to nuclear receptors.

Kendall W Nettles1, Geoffrey L Greene.   

Abstract

Nuclear receptors modulate transcription through ligand-mediated recruitment of transcriptional coregulator proteins. The structural connection between ligand and coregulator is mediated by a molecular switch, made up of the most carboxy-terminal helix in the ligand-binding domain, helix 12. The dynamics of this switch are thought to underlie ligand specificity of nuclear receptor signaling, but the details of this control mechanism have remained elusive. This review highlights recent structural work on how the ligand controls this molecular switch and the modulation of this signaling pathway by receptor subtype and dimer partner.

Mesh:

Substances:

Year:  2005        PMID: 15709961     DOI: 10.1146/annurev.physiol.66.032802.154710

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  83 in total

1.  Improved docking, screening and selectivity prediction for small molecule nuclear receptor modulators using conformational ensembles.

Authors:  So-Jung Park; Irina Kufareva; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2010-05-09       Impact factor: 3.686

2.  Dynamical probing of allosteric control in nuclear receptors.

Authors:  Mark A Cunningham
Journal:  J Mol Model       Date:  2012-01-06       Impact factor: 1.810

Review 3.  Structural and functional insights into nuclear receptor signaling.

Authors:  Lihua Jin; Yong Li
Journal:  Adv Drug Deliv Rev       Date:  2010-08-17       Impact factor: 15.470

4.  The receptor concept: pharmacology's big idea.

Authors:  H P Rang
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

5.  Integrative content-driven concepts for bioinformatics "beyond the cell".

Authors:  Edgar Wingender; Torsten Crass; Jennifer D Hogan; Alexander E Kel; Olga V Kel-Margoulis; Anatolij P Potapov
Journal:  J Biosci       Date:  2007-01       Impact factor: 1.826

6.  Structural plasticity in the oestrogen receptor ligand-binding domain.

Authors:  Kendall W Nettles; John B Bruning; German Gil; Erin E O'Neill; Jason Nowak; Yuee Guo; Alun Hughs; Younchang Kim; Eugene R DeSombre; Robert Dilis; Robert N Hanson; Andrzej Joachimiak; Geoffrey L Greene
Journal:  EMBO Rep       Date:  2007-04-27       Impact factor: 8.807

7.  Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.

Authors:  Lonnele J Ball; Nitzan Levy; Xiaoyue Zhao; Chandi Griffin; Mary Tagliaferri; Isaac Cohen; William A Ricke; Terence P Speed; Gary L Firestone; Dale C Leitman
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

8.  Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.

Authors:  Na Wang; Qingan Zou; Jinxin Xu; Jiancun Zhang; Jinsong Liu
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

9.  The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice.

Authors:  Anna E Börjesson; Helen H Farman; Cecilia Engdahl; Antti Koskela; Klara Sjögren; Jenny M Kindblom; Alexandra Stubelius; Ulrika Islander; Hans Carlsten; Maria Cristina Antal; Andrée Krust; Pierre Chambon; Juha Tuukkanen; Marie K Lagerquist; Sara H Windahl; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

10.  Synthesis of biphenyl proteomimetics as estrogen receptor-alpha coactivator binding inhibitors.

Authors:  Anna B Williams; Patrick T Weiser; Robert N Hanson; Jillian R Gunther; John A Katzenellenbogen
Journal:  Org Lett       Date:  2009-12-03       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.